Immucell Corp /De/ (NASDAQ: ICCC)

$7.82 +0.10 (+1.30%)
As of Apr 22, 2026 10:41 AM
Sector: Healthcare Industry: Biotechnology CIK: 0000811641
Market Cap 67.97 Mn
P/E -62.75
P/S 2.46
Div. Yield 0.00
ROIC (Qtr) -0.01
Total Debt (Qtr) 9.10 Mn
Revenue Growth (1y) (Qtr) -1.61
Add ratio to table...

About

Immucell Corp /De/ specializes in the development and sale of products designed to enhance the health and productivity of dairy cattle. The company operates within the agricultural biotechnology sector, focusing on solutions that address common challenges faced by dairy farmers, such as mastitis and other health issues that can impact milk production and quality. Immucell Corp /De/ leverages its expertise in biotechnology to create innovative products that support the well-being of dairy cattle, thereby contributing to the efficiency and profitability...

Read more

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn